Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Currently, a 10-day concomitant therapy has been reported to be equally effective and safe to
the 10-day sequential therapy for 1st-line anti-Helicobacter pylori(H. pylori) therapy. To
our knowledge, there has been no report concerning the efficacy of this regimen used as a
rescue therapy.
The aims of this study are:
1. to compare the efficacy of high dose dual therapy and concomitant therapy as rescue
regimen in H. pylori eradication;
2. to compare the patient adherence and adverse effects of these treatment regimens;
3. to investigate factors that may influence H. pylori eradication by these treatment
regimens.